Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1114021

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1114021

North America OTC Health Products Market Size, Share & Trends Analysis Report By Application (Digestive Health, Women's Health, Weight Control), By Product, By Form, By Demography, By Distribution Channel, And Segment Forecasts, 2022 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

North America OTC Health Products Market Growth & Trends:

The North America OTC health products market size is expected to reach USD 106.6 billion by 2030, expanding at a CAGR of 6.04% during the forecast period, according to a new report by Grand View Research, Inc. Rising consumer awareness and increasing consumer willingness to spend on nutritional supplements, the increasing prevalence of lifestyle diseases including obesity & diabetes, rise in disposable income, and an increase in the number of distribution channels for OTC products are some of the key factors driving growth. Consumers are increasingly realizing the benefits of nutritional supplements, which help them sustain a healthy lifestyle, thereby positively impacting the market growth. According to the National Institute of Health, Americans spend around USD 2.1 billion annually on weight-loss dietary supplements, usually in the form of pills.

The emergence of e-commerce has led to increased accessibility to dietary and nutritional supplements. Apart from the online channels, companies such as General Nutrition Centers, Inc.; Walmart; and Vitamin Shoppe are some of the major retail outlets. Thus, the easy availability of these products will provide growth opportunities to key players in this space. Moreover, shifting consumer preference to CBD due to its healing properties and limited to no psychoactive effects is expected to drive the growth potential for CBD-infused products. According to Gallup, Inc. report of 2019, approximately 14% of individuals in the U.S. have used some or the other form of CBD-infused products. About 58% of adults use it for pain-related conditions and around 42% for mental health-related conditions.

The COVID-19 pandemic resulted in a surge in consumer preference for immunity-boosting supplements. Segments such as sports nutrition, and women's & men's health saw a negative impact due to lockdowns imposed by governments to curb the pandemic. The effect of COVID-19 declined post the third quarter of 2020, which helped the market regain traction.

The market is fragmented with the presence of a large number of companies, intensifying the overall competitive rivalry. Companies are undertaking multiple partnerships and mergers & acquisitions to increase their portfolio & expand their footprint across the country. In addition, companies are focusing on product differentiation and bundling strategies to capture a greater market share. For instance, in March 2022, CV Sciences, Inc. launched PlusCBD Relief Softgels. The company claims that it can deliver seven times better Cannabidiol Acid (CBDA) and Cannabidiol (CBD) than its raw formula. This product has clinical significance in the treatment of inflammatory responses.

North America OTC Health Products Market Report Highlights:

  • The dietary supplements and weight loss products segment accounted for 35.07% of the share in 2021. This is attributed to an increase in consumer awareness about the benefits of a healthy diet, growing self-health consciousness, and a rise in the prevalence of obesity
  • The sports formulation segment accounted for the largest share of 20.49% in 2021 due to rising awareness about fitness and high commercial availability of sports nutrition
  • Adults segment is projected to witness the fastest growth during the forecast period owing to the availability of a wide variety of OTC products for the adult demographic
  • Hypermarkets, supermarkets, and convenience stores dominated the market in 2021, owing to the better feasibility of buying from such places and an increase in the number of strategic initiatives like schemes such as loyalty programs
  • The capsules & tablets segment dominated the market in 2021. This can be attributed to the wide availability of products in capsule & tablet form in the market, the rise in innovation to enhance capsules & tablets delivery forms, and higher shelf-life
  • The U.S. dominated the market in terms of revenue, mainly due to the presence of key players, an increase in the prevalence of chronic diseases & obesity, and a rapidly growing geriatric population
Product Code: GVR-4-68039-951-7

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
    • 1.3.6 List of Primary Sources
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
  • 1.7 North America Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Regulatory Landscape
  • 3.3 North America OTC health products Market dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
  • 3.4 User Perspective Analysis

Chapter 4 North America OTC Health Products Market - Segment Analysis, by Product, 2018 - 2030 (USD Billion)

  • 4.1 North America OTC Health Products Market: Product Movement Analysis
  • 4.2 Cough, Cold, and Flu Products
    • 4.2.1 Cough, Cold, And Flu Products Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.2.2 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.2.3 Capsules/Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.2.4 Gummies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.2.5 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 4.3 Dietary Supplements and Weight Loss Products
    • 4.3.1 Dietary Supplements and Weight Loss Products Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.3.2 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.3.3 Capsules/Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.3.4 Gummies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.3.5 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 4.4 Sports Nutrition Products
    • 4.4.1 Sports Nutrition Products Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.4.3 Capsules/Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.4.4 Gummies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.4.5 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 4.5 Probiotics
    • 4.5.1 Probiotics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.2 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.3 Capsules/Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.4 Gummies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.5 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 4.6 CBD Nutraceutical Products
    • 4.6.1 CBD Nutraceutical Products Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.6.3 Capsules/Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.6.4 Gummies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.6.5 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 5 North America OTC Health Products Market - Segment Analysis, by Application, 2018 - 2030 (USD Billion)

  • 5.1 North America OTC Health Products Market: Application Movement Analysis
  • 5.2 Digestive Health
    • 5.2.1 Digestive Health Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.3 Women's & Men's Health
    • 5.3.1 Women's & Men's Health Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.4 Weight Control
    • 5.4.1 Weight Control Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.5 Joint Health
    • 5.5.1 Joint Health Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.6 Immune Defense
    • 5.6.1 Immune Defense Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.7 Sports Formulation
    • 5.7.1 Sports Formulation Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 5.8 Others
    • 5.8.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 6 North America OTC Health Products Market - Segment Analysis, By Form, 2018 - 2030 (USD Billion)

  • 6.1 North America OTC Health Products Market: Form Movement Analysis
  • 6.2 Liquid
    • 6.2.1 Liquid Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 6.3 Capsules & Tablets
    • 6.3.1 Capsules & Tablets Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 6.4 Gummy
    • 6.4.1 Gummy Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 6.5 Others
    • 6.5.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 7 North America OTC Health Products Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Billion)

  • 7.1 North America OTC Health Products Market: Distribution Channel Movement Analysis
  • 7.2 Retail Pharmacy
    • 7.2.1 Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 7.3 Online
    • 7.3.1 Online Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 7.4 Hypermarkets, Supermarkets, And Convenience Stores
    • 7.4.1 Hypermarkets, Supermarkets, Convenience Stores Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 7.5 Others
    • 7.5.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 8 North America OTC Health Products Market - Segment Analysis, By Demography, 2018 - 2030 (USD Billion)

  • 8.1 North America OTC Health Products Market: Demography Movement Analysis
  • 8.2 Children
    • 8.2.1 Children Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 8.3 Adults
    • 8.3.1 Adults Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 9 North America OTC Health Products Market - Segment Analysis, By Region, 2018 - 2030 (USD Billion)

  • 9.1 North America OTC Health Products Market, Market Share by Region, 2021 & 2030
  • 9.2 North America
    • 9.2.1 North America Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 9.3 U.S.
    • 9.3.1 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • 9.4 Canada
    • 9.4.1 Canada Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 10 North America OTC Health Products Market - Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 10.1.1 New Product Launch
    • 10.1.2 Joint Ventures
    • 10.1.3 Mergers and Acquisitions
    • 10.1.4 Licensing Agreements
  • 10.2 Company Categorization
    • 10.2.1 Market Differentiators
    • 10.2.2 List of Key Private Label Manufacturers
  • 10.3 Public Companies
    • 10.3.1 Company Market Position Analysis
    • 10.3.2 Competitive Dashboard Analysis

Chapter 11 Company Profiles

  • 11.1 GlaxoSmithKline plc
    • 11.1.1 Company Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Benchmarking
    • 11.1.4 Strategic Initiatives
  • 11.2 Bayer AG
    • 11.2.1 Company Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Benchmarking
    • 11.2.4 Strategic Initiatives
  • 11.3 Johnson & Johnson Services, Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Benchmarking
    • 11.3.4 Strategic Initiatives
  • 11.4 Herbalife Nutrition Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Benchmarking
    • 11.4.4 Strategic Initiatives
  • 11.5 CV Sciences, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Benchmarking
    • 11.5.4 Strategic Initiatives
  • 11.6 Medical Marijuana Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Benchmarking
    • 11.6.4 Strategic Initiatives
  • 11.7 American Health
    • 11.7.1 Company Overview
    • 11.7.2 Product Benchmarking
  • 11.8 THE BOUNTIFUL COMPANY (Nestle Health Science S.A.)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Benchmarking
    • 11.8.4 Strategic Initiatives
  • 11.9 Nature's Sunshine Products, Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Benchmarking
    • 11.9.4 Strategic Initiatives
  • 11.10 Seattle Gummy Company
    • 11.10.1 Company Overview
    • 11.10.2 Product Benchmarking
    • 11.10.3 Strategic Initiatives
Product Code: GVR-4-68039-951-7

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 4 North America OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 6 North America OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 7 North America OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 8 U.S. OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 9 U.S. OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 11 U.S. OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 12 U.S. OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)
  • Table 13 Canada OTC health products market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • Table 14 Canada OTC health products market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15 Canada OTC health products market estimates and forecasts, by form, 2018 - 2030 (USD Billion)
  • Table 16 Canada OTC health products market estimates and forecasts, by demography, 2018 - 2030 (USD Billion)
  • Table 17 Canada OTC health products market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 North America OTC health products market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 North America OTC health products market snapshot (USD Billion)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 North America OTC health products market driver impact
  • Fig. 13 North America OTC health products market restraint impact
  • Fig. 14 North America OTC health products market: Product outlook and key takeaways
  • Fig. 15 North America OTC health products market: Product movement analysis
  • Fig. 16 Cough, cold, and flu products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 17 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 18 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Dietary supplements and weight loss products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Sports nutrition products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Probiotics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 CBD nutraceutical products market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 Capsules/Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Gummies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 North America OTC health products market: Application outlook and key takeaways
  • Fig. 42 North America OTC health products market: Application movement analysis
  • Fig. 43 Digestive health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Women's & men's health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Weight control market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Joint health market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Immune defense market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Sports formulation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 North America OTC health products market: Form outlook and key takeaways
  • Fig. 51 North America OTC health products market: Form movement analysis
  • Fig. 52 Liquid market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Gummy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 North America OTC health products market: Distribution channel outlook and key takeaways
  • Fig. 57 North America OTC health products market: Distribution channel movement analysis
  • Fig. 58 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Online market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Hypermarkets, supermarkets, convenience stores market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 North America OTC health products market: Demography outlook and key takeaways
  • Fig. 63 North America OTC health products market: Demography movement analysis
  • Fig. 64 Children market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Regional outlook, 2021 & 2030
  • Fig. 67 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 68 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 69 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 70 Market differentiators
  • Fig. 71 Market position analysis (2021)
  • Fig. 72 Profit margin (2021)
  • Fig. 73 Dashboard Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!